Indian companies are making massive investment pledges in the US, led by Essar Group's $18 billion steel complex and Sun Pharma's $11.75 billion acquisition, driven partly by US protectionist tariffs and demands for investment in exchange for market access under a bilateral trade deal.
Exam Lens
Quick Exam Facts From News
1-Minute Revision
- ›Essar Group Investment: $18 billion for integrated steel complex in US
- ›Sun Pharma Acquisition: $11.75 billion for Organon & Co.
- ›Target this Data: Essar Group's $18 billion investment for US steel complex
- ›Target this Data: US doubled steel tariffs to 50% under Section 232
- ›Target this Data: India's net FDI in July 2026 was $7.35 billion (5-year high)
Mastered this topic? Test your knowledge with a full MCQ quiz.
Practice exam-style questions, track your score, and strengthen your recall.